Open-label, single centre, phase I pharmacokinetic study of DSC 127 in diabetic patients with chronic non-healing foot ulcers

Trial Profile

Open-label, single centre, phase I pharmacokinetic study of DSC 127 in diabetic patients with chronic non-healing foot ulcers

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2013

At a glance

  • Drugs Aclerastide (Primary)
  • Indications Diabetic foot ulcer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top